You are here: Industry Insights > COVID-19

News List

Almac Secures Grant for Remdesivir Manufacturing for COVID-19 americanpharmaceuticalreview
December 01, 2020
Almac Sciences has been awarded a grant of approximately $500,000 by the COVID-19 Therapeutics Accelerator towards developing cost effective, scalable processes for the production of the active pharmaceutical ingredient (API) of the drug remdesivir.
SGS Initiates COVID-19 Clinical Trials in U.S. contractpharma
December 01, 2020
Phase 2/3 trial will examine the safety, tolerability, and efficacy of Sarconeos (BIO101) to treat COVID-19 related respiratory failure.
Expect to commercialise vaccine facility by April-May 2021: Aurobindo Pharma expresspharma
December 01, 2020
It is investing around Rs 275 crores on the facility to produce vaccines for the treatment of various viral diseases including COVID-19.
Gilead Sciences, AIDS Society of India survey highlights disruption in HIV care during COVID-19 expresspharma
December 01, 2020
Gilead Sciences and the AIDS Society of India announced findings from a pulse survey conducted to evaluate the impact of the COVID-19 pandemic on access and delivery of HIV care in the Asia Pacific.
UK to procure additional two million doses of mRNA vaccine against COVID-19 expresspharma
December 01, 2020
Moderna announced a supply agreement with the UK government for an additional two million doses of mRNA-1273, Moderna’s vaccine candidate against COVID-19, to the United Kingdom beginning in March 2021.
Moderna announces vaccine efficacy of 94.1 per cent, to file for EUA with US FDA expresspharma
December 01, 2020
Primary efficacy analysis of the Phase 3 COVE study of mRNA-1273 involving 30,000 participants included 196 cases of COVID-19, of which 30 cases were severe.
Putting the vulnerable first could end the pandemic faster expresspharma
December 01, 2020
The role of serendipity in science came to the fore yet again when AstraZeneca and the University of Oxford revealed that a dosing error was at the heart of their COVID-19 vaccine candidate being tested as a half-dose followed by a full dose.
RedHill Biopharma Expands U.S.-Based Manufacturing Capacity of Opaganib for COVID-19 prnasia
November 30, 2020
RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced partnerships with two leading, U.S.-based manufacturers for large-scale manufacturing of opaganib.
Predict cellular drug targets against COVID-19 worldpharmanews
November 30, 2020
A computational model of a human lung cell has been used to understand how SARS-CoV-2 draws on human host cell metabolism to reproduce by researchers at the University of Warwick.
FDA defers approval of DaxibotulinumtoxinA for Injection in glabellar lines due to Covid-19 related travel restrictions pharmaceutical-business-review
November 30, 2020
Revance Therapeutics announced that the United States (U.S.) Food and Drug Administration (FDA) has deferred a decision on the Biologics License Application (BLA) for DaxibotulinumtoxinA for Injection, an investigational neuromodulator product for the ...